Moreover, rodent studies using acetylcholinesterase blockers, e.g., PYR and donepezil, described an attenuation of the progression of both cardiac remodeling and cardiac dysfunction, as well as improvement of the long-term survival of animals with heart failure [14], [20], [56], [57]. The gene discussed is ACHE; the disease is heart failure.